Emergent BioSolutions, a global life sciences company offering specialty products and contract development and manufacturing services, announced a $75 million […]
Blood-thinning drugs could be used to help save coronavirus patients by preventing dangerous clots forming on their lungs, British doctors […]
Mount Sinai Health System will be conducting a study using remestemcel-L (Ryoncil), an innovative allogeneic stem cell therapy in patients […]
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Mount Sinai Laboratory (MSL), Center for Clinical […]
Physicians/Investigators from the Icahn School of Medicine at Mount Sinai suspect that lung-based blood clots may play a role in […]
Harbour Biomed, a biotech collaborating with Mount Sinai to work on a drug targeting coronavirus, closed $75 million from investors […]
Mount Sinai Researchers have discovered that dupilumab (Dupixent, Sanofi) may represent a therapeutic option for keloids as during a recent […]
A revolution of sorts in genetic discoveries over the past couple decades has pushed the envelope in advanced understanding of […]
Mount Sinai Medical Center, internationally acclaimed for its excellence in research, patient care, education in multiple sclerosis and a range […]
A recent study sponsored by Icahn School of Medicine, Mount Sinai and the American Heart Association found that both individual […]
